Upcoming Earnings: Q2 '26
Estimated EPS
-$0.50
Estimated Rev
$6.35M
$BSEM Q1 '26 Earnings Results & Recap BioStem Technologies expects full year 2026 revenue to range from $25M to $29M, with sequential growth in both hospital and physician office businesses anticipated in the second half of 2026.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q2 '26 | -$0.50 | -- | -- | N/A |
Q1 '26 | -$0.28 | -$0.52 | -85.71% | MISSED |
Q4 '25 | $0.02 | -$0.67 | -3450.00% | MISSED |
Q3 '25 | $0.00 | $0.03 | 100.00% | BEAT |
Q2 '25 | $0.32 | -$0.03 | -109.38% | MISSED |